Polyrizon Provides 2025 and Recent Highlights
Polyrizon Ltd., a pre-clinical-stage biotech company specializing in intranasal protective hydrogels, announced key achievements in 2025 and early 2026 including progress with the FDA on clinical trial strategies, preparation of clinical trial materials, positive preclinical results, and expansion into potential new revenue streams such as private …